Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03660553 · ClinicalTrials.gov registry record · Phase 4
Simplified Insulin Regimen for the Elderly
A Phase 4 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT03660553: Clinical Trial Phase 4 study, sponsored by University of Miami.
NCT03660553 is a Phase 4 study that was terminated before completion, run by University of Miami. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03660553, a Phase 4 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
Basal-bolus insulin therapy, which includes one injection of long acting insulin and three injections of short acting insulin is the most commonly used insulin treatment. However, many older patients find the basal-bolus insulin regimen hard to manage because it involves 4 injections and 4 blood glucose tests each day. It is possible that a simplified treatment that involves one injection of long acting insulin daily and two blood glucose tests daily might be equally effective. This simplified regimen, if effective, would be easier to use and might result in less errors. Therefore, the investigators want to conduct this study to compare using a single daily injection of basal insulin with the usual basal-bolus insulin regimen in elderly patients (age \>65 years) with type 2 diabetes.
Primary Outcome
The mean HbA1c in the BI group will be compared to the mean HbA1c in the MSI group
Interventions
- DRUG Insulin Glargine
- DRUG Insulin Lispro
- DRUG Insulin Aspart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 4 |
Why NCT03660553 stopped before completion
NCT03660553 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Insulin Glargine is the first listed.
NCT03660553 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03660553 about?
NCT03660553 is a clinical study titled "Simplified Insulin Regimen for the Elderly". Basal-bolus insulin therapy, which includes one injection of long acting insulin and three injections of short acting insulin is the most commonly used insulin treatment. However, many older patients find the basal-bolus insulin regimen hard to manage because it involves 4 injections and 4 blood glu...
What is the current status of trial NCT03660553?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2018-10-10. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03660553?
The interventions under investigation include: Insulin Glargine (DRUG), Insulin Lispro (DRUG), Insulin Aspart (DRUG).
Who is sponsoring clinical trial NCT03660553?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03660553's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI